Nanjing Medical Selling assets support performance president resignation personnel unrest intensifies

Every reporter Mong Lin on the sale of assets to achieve the medium-term profit, Nanjing Medicine (600713, closing price of 5.37 yuan) seems to be in this regard "addiction." Recently, the Nanjing Medical Bulletin said that the 37 million yuan to sell the listed price of its two e-commerce companies. At the same time, after the company's chairman, vice president after the departure, the company's president also announced for "personal reasons" resign. Sale of assets Nanjing Medicine announced today that the proposed listing of two E-commerce enterprises in Beijing Green Gold 50% of the equity and Jiangsu Green Collar 60% of the stake, the listing price of 37 million yuan. The company said that E-commerce enterprises in the latter part of the development process needs to invest a lot of cash, and the company's main business capital demand is large, it is difficult to continue to invest money. Data show that Beijing Green Gold was founded in April 2011, after the establishment of sustained losses, as of May 2013 net assets for-26.91 million yuan, this January ~ May of 9.72 million yuan. Jiangsu Green Collar was established in 2012, the registered capital of 50 million yuan, according to the plan of Nanjing medicine to pay 30 million, Zhang Wenjun recognized 20 million yuan. But at present Nanjing Medicine has invested 30 million yuan, Zhang Wenjun capital investment still not in place. By the end of May, Jiangsu Green Collar net assets of 24.69 million yuan, the January to May net profit loss of 2.28 million yuan. The daily economic news reporter found that Nanjing medicine for the above two assets sold at a price of 37 million yuan, and the previous input cost of 36 million yuan, which means that even if it sold smoothly, in the operation of three years after the Nanjing medical only reluctantly recover investment costs. For the remaining equity Holdings, Nanjing Medical said the company plans to transform into an industrial investor in the field of E-commerce and gain fixed income as an equity shareholder. The resignation of the president in the announcement of asset sales, Nanjing Pharmaceutical also announced that the company's director, President He Jinxian resigned for personal reasons. "Daily economic news" Reporter noted that this is the former chairman of Zhou Yaoping after his departure in March, the third to leave the Nanjing medical executives. In April this year, Ding, the original director and executive vice president of Nanjing Medicine, resigned for personal reasons. Zhou Yaoping After leaving, the new chairman Tao from Nanjing Commercial Building "airborne", Nanjing Pharmaceutical began to sell assets frequently to support performance. Since March this year, Nanjing Medicine has announced the transfer or listed the sale of Fuzhou rejuvenation Chinese herbal pieces factory, Nanjing Tongren Temple Huangshan Refining pharmaceutical companies, such as 12 holding, equity stakes in the company. Relying on the sale of assets to bring 50.87 million yuan non-recurrent income, the first half of this year, Nanjing medicine to achieve a net profit of 16.43 million yuan, but if deducted from the non-recurrent profit and loss, its actual loss of 14.88 million yuan. Some people in the market expressed concern: "Rely on the sale of assets to maintain performance, in the main business is still weak, the management of the company has repeatedly changed, it is difficult not to the company's business operations have a negative impact." "Data show that 1969 was born in the He Jinxian, with a doctorate in political economics, 2006 ~2007 years in February, deputy general manager of Nanjing High Branch, Dong Secret; 2007In March, He Jinxian entered Nanjing Medicine and became vice president of the company, and since then, he was appointed Chief Secretary of the office for the former Dong, and has been a director and President of Nanjing Medicine since December 2011.